Indeed, the deleterious effect of diabetes on kidney function is reflected in the 12-fold increase in incidence of all-cause ESRD in men with diabetes compared with their nondiabetic counterparts [1]. Nephrologists will see increasingly large numbers of diabetic patients with CKD, ESRD and post-...
Diabetes mellitus is a disease marked by high levels of blood glucose resulting from defects in insulin production (type 1 diabetes) or insulin sensitivity (type 2 diabetes). Symptoms of diabetes include weight loss, polyuria, polydipsia, and polyphagia. Type 2 diabetes (T2DM) represents approxima...
et al. A validated prediction model for end-stage kidney disease in type 1 diabetes. Diabetes Care 44, 901–907 (2021). Article PubMed Google Scholar Vistisen, D. et al. Prediction of first cardiovascular disease event in type 1 diabetes mellitus: the steno type 1 risk engine. ...
Objective To investigate the kidney function of type 2diabetes mellitus and explore the influencing factors in Taiyuan. Methods Selected 242 type 2diabetes mellitus patients as subjects.Questionnaire was used to collect the general information.Physical examination was also performed.Blood pressure,FPG,blood...
Diabetes mellitus (DM) is the leading cause of chronic kidney disease (CKD). Optimal glycemic control contributes to improved outcomes in patients with DM, particularly for microvascular damage, but blood glucose levels are too variable to provide an accurate assessment and instead markers averaging ...
1、Type 1 Diabetes Mellitus (T1DM): Etiology: Type 1 diabetes is considered an autoimmune disease where the body's immune system attacks and destroys the insulin-producing beta cells in the pancreas. As a result, people with T1DM produce little to no insulin. ...
In type 1 diabetes mellitus, pancreatic beta cells that produce insulin are affected. And ultimately, the iron loses its ability to produce this vital hormone. In type 2 diabetes, the pancreas can still produce some insulin, but it is not sufficient for the body to function fully. ...
Sodium-glucose cotransporter 2 inhibitors (SGLT-2i) have demonstrated efficacy in reducing cardiovascular events and potentially improving kidney function in diabetic patients. Here, using the TriNetX platform, the authors show that SGLT-2 inhibitors reduce all-cause mortality and major adverse cardiac ...
To determine whether abnormalities of hypothalamic-pituitary-adrenal axis function occur in type I diabetes mellitus, corticotropin, cortisol, 17-hydroxypr... L Ghizzoni,M Vanelli,R Virdis,... - 《Metabolism Clinical & Experimental》 被引量: 31发表: 1993年 Increased levels of cortisol and IGF...
Effect of Experimental Diabetes Mellitus, Kidney, Rat 来自 Semantic Scholar 喜欢 0 阅读量: 6 作者: H Wehner 摘要: Diabetic rat kidneys are larger than those of normal rats of corresponding age. The capsular surface is usually smooth. A fine granulation can occur in late stages. The cut ...